Northern Trust’s Imago BioSciences IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-260,917
Closed -$9.38M – 4701
2022
Q4
$9.38M Buy
260,917
+11,194
+4% +$280K ﹤0.01% 2056
2022
Q3
$3.76M Buy
249,723
+24,712
+11% +$401K ﹤0.01% 2660
2022
Q2
$3.01M Buy
225,011
+48,678
+28% +$773K ﹤0.01% 2831
2022
Q1
$3.4M Buy
176,333
+69,211
+65% +$1.44M ﹤0.01% 2809
2021
Q4
$2.54M Buy
107,122
+21,413
+25% +$496K ﹤0.01% 3109
2021
Q3
$1.72M Buy
+85,709
New +$1.84M ﹤0.01% 3362

Northern Trust's IMGO Position: Q1 2023 in Review

Northern Trust sold out of Imago BioSciences (IMGO) in Q1 2023, closing a stake of 260,917 shares — an estimated $9.38M sold.

Northern Trust first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $9.38M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Northern Trust reported no remaining Imago BioSciences position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 260,917 Imago BioSciences shares in Q1 2023, an estimated $9.38M.
  • Northern Trust first reported a position in Imago BioSciences in Q3 2021 and held it in 6 quarters.
  • Northern Trust's Imago BioSciences position peaked at $9.38M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.